Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Patent
1997-07-23
1998-04-28
McKane, Joseph
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
514424, 514429, 548413, 548541, 548578, A61K 3140, C07D20704
Patent
active
057444587
ABSTRACT:
Compounds having kappa opioid agonist activity, compositions containing them and method of using them as analgesics are provided.
The compound of formula II has the structure: ##STR1## wherein X.sub.4, X.sub.5 ;
REFERENCES:
patent: 4065573 (1977-12-01), Lednicer
patent: 4098904 (1978-07-01), Szmuszkovicz
patent: 4145435 (1979-03-01), Szmuszkovicz
patent: 4212878 (1980-07-01), Lednicer et al.
patent: 4359476 (1982-11-01), Kaplan et al.
patent: 4438130 (1984-03-01), Kaplan
patent: 4663343 (1987-05-01), Horwell et al.
patent: 4855316 (1989-08-01), Horwell et al.
patent: 4906655 (1990-03-01), Horwell et al.
McMahon et al., TINS, vol. 15, No. 12 (1992).
Bernstein et al., Journal of Investigative Dermatology, 78: 82-83 (1982).
Ballantyne et al., Pain, 33: 149-160 (1988).
J. D. Bernhard, J. Am. Acad. Derm. 24: 309 (1991).
IASP Newsletter, Sep./Oct. 1996.
Thomas et al., Brain Research, 695: 267-270 (1995).
CA 115: 8474w Naphto and benzo . . . benzeneacetamide. Freeman et al., p. 827. 1991.
CA 120: 544309e DuP 747: structure activity relationship study. Rajagopalan et al.p. 968. 1994.
Chang An-Chih
DeHaven-Hudkins Diane L.
Farrar John J.
Gaul Forrest
Kruse Lawrence I.
Adolor Corporation
Balogh Imre
McKane Joseph
LandOfFree
Kappa agonist compounds and pharmaceutical formulations thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Kappa agonist compounds and pharmaceutical formulations thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Kappa agonist compounds and pharmaceutical formulations thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1532072